Empagliflozin is used to lower blood sugar levels in adults with type 2 diabetes who have failed to achieve control by diet and exercise alone.
How it works
Empagliflozin belongs to a class of drugs called sodium-glucose co-transporter 2 (SGLT2) inhibitors. Empagliflozin acts by blocking the action of SGLT2 which causes kidneys to clear more glucose in the urine, thereby lowering blood sugar levels in the blood
Common side effects
Cloudy urine, Fall in blood sugar level
- Continue to follow the diet and exercise program recommended by your doctor.
- Inform your doctor, if you have a history of or are suffering from kidney problems, low or high blood pressure, or high cholesterol.
- Exercise caution if you are an elderly patient.
- Keep yourself hydrated, especially during hot weather or while you are being active as dehydration may increase the risk of empagliflozin's side effects.
- Inform your doctor if you develop urinary tract infections or problems with urination.
- You will be regularly monitored for cholesterol levels, kidney function, fasting blood glucose, and hemoglobin A1c while taking empagliflozin.
- Seek immediate medical attention if you experience nausea, vomiting, shortness of breath, sweating and weakness or any such symptoms indicative of hypoglycemia (low blood sugar) while on empagliflozin.
- Do not drive or operate machinery during empagliflozin therapy as it may cause drowsiness.
- Do not consume alcohol when on treatment with empagliflozin, as it may worsen its side effects.
- Tell your doctor if you are pregnant or planning to become pregnant or are breastfeeding.
- Do not take if allergic to empagliflozin or any of its ingredients.
- Do not take if suffering from type 1 diabetes.
- Do not take with diabetic ketoacidosis (high blood or urine ketone levels).
- Do not take if below 18 years of age.